2ios
From Proteopedia
m (Protected "2ios" [edit=sysop:move=sysop]) |
|||
Line 1: | Line 1: | ||
- | [[Image:2ios.png|left|200px]] | ||
- | |||
{{STRUCTURE_2ios| PDB=2ios | SCENE= }} | {{STRUCTURE_2ios| PDB=2ios | SCENE= }} | ||
- | |||
===Crystal structure of the C-terminal MA3 domain of Pdcd4 (mouse); form 3=== | ===Crystal structure of the C-terminal MA3 domain of Pdcd4 (mouse); form 3=== | ||
+ | {{ABSTRACT_PUBMED_17060447}} | ||
- | + | ==Disease== | |
+ | [[http://www.uniprot.org/uniprot/PDCD4_MOUSE PDCD4_MOUSE]] Note=Decreases benign tumor development and malignant progression. | ||
+ | |||
+ | ==Function== | ||
+ | [[http://www.uniprot.org/uniprot/PDCD4_MOUSE PDCD4_MOUSE]] Inhibits translation initiation and cap-dependent translation. May excert its function by hindering the interaction between EIF4A1 and EIF4G. Inhibits the helicase activity of EIF4A. Modulates the activation of JUN kinase. Down-regulates the expression of MAP4K1, thus inhibiting events important in driving invasion, namely, MAPK85 activation and consequent JUN-dependent transcription. May play a role in apoptosis. Tumor suppressor. Inhibits tumor promoter-induced neoplastic transformation. Binds RNA.<ref>PMID:12482958</ref><ref>PMID:12894233</ref><ref>PMID:16024603</ref><ref>PMID:17060447</ref> | ||
==About this Structure== | ==About this Structure== | ||
Line 14: | Line 16: | ||
==Reference== | ==Reference== | ||
- | <ref group="xtra">PMID:017060447</ref><references group="xtra"/> | + | <ref group="xtra">PMID:017060447</ref><references group="xtra"/><references/> |
[[Category: Mus musculus]] | [[Category: Mus musculus]] | ||
[[Category: LaRonde-LeBlanc, N A.]] | [[Category: LaRonde-LeBlanc, N A.]] |
Revision as of 23:15, 24 March 2013
Contents |
Crystal structure of the C-terminal MA3 domain of Pdcd4 (mouse); form 3
Template:ABSTRACT PUBMED 17060447
Disease
[PDCD4_MOUSE] Note=Decreases benign tumor development and malignant progression.
Function
[PDCD4_MOUSE] Inhibits translation initiation and cap-dependent translation. May excert its function by hindering the interaction between EIF4A1 and EIF4G. Inhibits the helicase activity of EIF4A. Modulates the activation of JUN kinase. Down-regulates the expression of MAP4K1, thus inhibiting events important in driving invasion, namely, MAPK85 activation and consequent JUN-dependent transcription. May play a role in apoptosis. Tumor suppressor. Inhibits tumor promoter-induced neoplastic transformation. Binds RNA.[1][2][3][4]
About this Structure
2ios is a 1 chain structure with sequence from Mus musculus. Full crystallographic information is available from OCA.
See Also
Reference
- LaRonde-LeBlanc N, Santhanam AN, Baker AR, Wlodawer A, Colburn NH. Structural basis for inhibition of translation by the tumor suppressor Pdcd4. Mol Cell Biol. 2007 Jan;27(1):147-56. Epub 2006 Oct 23. PMID:17060447 doi:10.1128/MCB.00867-06
- ↑ Yang HS, Jansen AP, Komar AA, Zheng X, Merrick WC, Costes S, Lockett SJ, Sonenberg N, Colburn NH. The transformation suppressor Pdcd4 is a novel eukaryotic translation initiation factor 4A binding protein that inhibits translation. Mol Cell Biol. 2003 Jan;23(1):26-37. PMID:12482958
- ↑ Bohm M, Sawicka K, Siebrasse JP, Brehmer-Fastnacht A, Peters R, Klempnauer KH. The transformation suppressor protein Pdcd4 shuttles between nucleus and cytoplasm and binds RNA. Oncogene. 2003 Jul 31;22(31):4905-10. PMID:12894233 doi:10.1038/sj.onc.1206710
- ↑ Jansen AP, Camalier CE, Colburn NH. Epidermal expression of the translation inhibitor programmed cell death 4 suppresses tumorigenesis. Cancer Res. 2005 Jul 15;65(14):6034-41. PMID:16024603 doi:65/14/6034
- ↑ LaRonde-LeBlanc N, Santhanam AN, Baker AR, Wlodawer A, Colburn NH. Structural basis for inhibition of translation by the tumor suppressor Pdcd4. Mol Cell Biol. 2007 Jan;27(1):147-56. Epub 2006 Oct 23. PMID:17060447 doi:10.1128/MCB.00867-06